Retraction: Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder. [PDF]
PLoS OnePLOS One Editors.
europepmc +1 more source
One-hot news: drug synergy models shortcut molecular features. [PDF]
BioinformaticsÇandır EB +4 more
europepmc +1 more source
Long-Term Adherence and Drug Utilisation Patterns Among New Users of Anti-Hyperlipidemic Monotherapy: Development of a Risk Prediction Model. [PDF]
J Eval Clin PractLi X +4 more
europepmc +1 more source
Comparison of rapid and same-day desensitization protocols in hypersensitivity reactions to platinum and taxanes: a retrospective cohort study. [PDF]
Front AllergyTorres Górriz MC +6 more
europepmc +1 more source
Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report. [PDF]
Front OncolLiu L, Ma L, Yang L, He W.
europepmc +1 more source
Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study. [PDF]
Front ImmunolChen SX +12 more
europepmc +1 more source
Glymphatic dysfunction as a predictor of response to lacosamide add-on therapy in drug-resistant focal epilepsy. [PDF]
Front NeurolLee DA, Wi JH, Lee HJ, Park KM.
europepmc +1 more source
Drug-coated balloons in complex large-vessel coronary artery disease: a comprehensive review of current evidence and future perspectives. [PDF]
Front Cardiovasc MedGitto M +11 more
europepmc +1 more source
Based a machine learning approach to investigate the factors influencing nirmatrelvir/ritonavir exposure in human plasma: a multicenter, observational study. [PDF]
Front Cell Infect MicrobiolZhang Y +6 more
europepmc +1 more source
Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases. [PDF]
Front MicrobiolTarashi S +3 more
europepmc +1 more source